RenovaCare products are under development and not approved for sale in the United States.
Results may vary from person to person.

Presentations

Date

Title

Video

Transcript

Presentation

01/19/2021

Noble Capital Markets Annual Presentation

10/29/20

Investor Summit Presentation

Latest Press Releases

RenovaCare Announces Management Changes

Scottsdale, AZ – March 24, 2022 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), clinical-stage developer of patented cell therapy technologies for the regeneration of skin and tissues, today announced reductions in its management team to further streamline administrative expenses.

Read more

RenovaCare Provides Clinical and Corporate Update

Scottsdale, AZ – March 09, 2022 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented cell therapy technologies for the regeneration of skin and tissues, today announced that following the review of its research and corporate activities, the Company is taking steps to streamline its clinical, research and development, and administrative operations in order to reduce costs.

Read more

Company Overview

RenovaCare, Inc. is committed to the highest standards of ethical behavior and the Company’s commitment extends to all aspects of its role as an employer and as a corporate citizen. This commitment to ethical behavior extends beyond mere compliance with laws and regulations to inspire our relationships with our shareholders, clients, and employees.

Corporate Office:

RenovaCare, Inc.
9375 E. Shea Blvd., Suite 107-A
Scottsdale, AZ 85260
1-888-398-0202

Sign Up for Investor Alerts